Can an investigator sign electronically?

Yes. Electronic signatures are valid under the federal ESIGN Act (15 U.S.C. §7001) and UETA where adopted, provided intent, consent, attribution, and record retention requirements are met.

Is HIPAA protection required?

If the report contains protected health information, use a platform that supports HIPAA and a signed BAA; retain records per 45 CFR §164.530(j).

How do I handle a missing signature?

Do not alter the signed PDF. Request the missing signature through the platform with an audit trail; document attempts and include the signed timestamp.

What if the sponsor requests additional detail?

Provide an addendum with dated entries and supporting source documents; note the report version and include PI attestation of accuracy.

Are remote notaries acceptable?

Remote online notarization (RON) is state‑dependent; verify state notary rules and retention of audio‑video recordings per the state notary commission.

How long should signed reports be retained?

Retain signed reports per study terms and regulatory standards: at minimum the study term plus three years, longer where HIPAA, FDA, or grant rules apply.

Electronic Signature
Templates
Miscellaneous
Research Investigator Site Report

Research Investigator Site Report

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Research Investigator Site Report

Study and Site Identification

Study Title Protocol Number Sponsor Name Site / Investigator Institution / Site Address

Contact Name

Phone

Email

Monitoring Visit Date

Report Date

IRB/EC Approval Date

Recitals

WHEREAS, Sponsor Name: is conducting the clinical study described by Protocol Number: ; and

WHEREAS, Site Name/Investigator: has agreed to enroll subjects and perform site activities in accordance with the protocol, applicable ethical standards, and regulatory requirements; and

WHEREAS, Sponsor and Site desire to document site performance, monitoring observations, and the administrative terms governing compensation and confidentiality as reflected in this Report and Agreement.

Scope of Work

The Site shall perform the following obligations in connection with the Protocol identified above. The description below shall be the operative scope for performance and billing.

Site Performance Metrics

Enrollment Target

Subjects Enrolled

Subjects Screened

Withdrawals / Lost to Follow-up

Monitoring Findings

Summary of monitoring observations, source data verification, informed consent documentation, investigational product handling, and regulatory binder review.

Protocol Deviations / Noncompliance

Serious Adverse Events (SAEs)

Facilities, Equipment, and Personnel Training

Payment Terms (Agreement)

The Sponsor shall compensate the Site for performance of the Scope of Work as follows. Payment shall be made in accordance with the invoicing requirements set forth below.

Total Agreed Amount Payment Schedule / Milestones Late Payment Fee

Invoices must reference protocol and subject IDs as required and shall be submitted in the format described above. Sponsor shall remit payment within the agreed payment period following receipt of a compliant invoice. Disputed amounts shall be raised in writing within fifteen (15) days of invoice receipt and will not relieve Sponsor of timely payment of undisputed portions.

Term and Termination

This Agreement commences on Start Date: and continues until End Date: , unless earlier terminated in accordance with this section.

Either party may terminate for convenience upon written notice delivered no fewer than days. Either party may terminate immediately for material breach that is not cured within thirty (30) days following written notice of such breach, or immediately if required by applicable law or regulatory authority.

Confidentiality

Each party shall maintain in confidence all proprietary and confidential information disclosed by the other party in connection with this Study and Report, including subject data and technical or financial information, and shall not disclose such information except to personnel with a need to know, or as required by law or institutional policy. Confidential information shall be used solely for performance of obligations under this Agreement. Obligations of confidentiality survive termination for a period of three (3) years, except for personally identifiable subject data, for which retention and confidentiality obligations are governed by applicable law and shall be maintained indefinitely as required.

Governing Law

This Agreement and any disputes or claims arising out of or in connection with it shall be governed by and construed in accordance with the laws of: without regard to conflict of law principles.

Entire Agreement

This Report, together with any attachments, exhibits, and referenced protocol documents expressly incorporated herein, constitutes the entire agreement between Sponsor and Site regarding the subject matter and supersedes all prior discussions, agreements, and understandings, whether written or oral. Any amendment must be in writing and signed by authorized representatives of both parties.

Corrective Actions and Follow-up

Follow-up Required

Yes No

Attachments

List of attachments submitted with this Report (monitoring logs, redacted source documentation summaries, correspondence, corrective action plans).

Certification: By signing below, each party certifies that the information contained in this Site Report is true and accurate to the best of their knowledge, that the Site conducted study activities in accordance with the protocol and applicable requirements except as noted, and that any required remedial actions and required reporting have been completed or will be completed as described above.

Sponsor Name:

By:

Date:

Investigator / Site Representative:

By:

Date:

What the Research Investigator Site Report Is

A Research Investigator Site Report is a structured document prepared by a clinical site to summarize study activities, enrollment, protocol deviations, safety events, regulatory status, and source‑document availability. It consolidates operational metrics and supporting records for sponsors, monitors, and institutional review boards (IRBs). The report typically includes protocol identifiers, visit logs, adverse event summaries, informed consent status, monitoring findings, and a checklist of regulatory documents to support audits and compliance reviews.

Why this report matters for study quality and compliance

A clear site report centralizes evidence required for monitoring, regulatory inspection, and sponsor oversight; it reduces ambiguity about enrollment, deviations, and safety signals while supporting timely corrective actions.

Primary users and audiences for the site report

The Research Investigator Site Report is completed and reviewed by clinical site staff, shared with sponsors and IRBs, and used by monitors and auditors to verify compliance and data integrity.

Principal Investigator: responsible for clinical oversight, attestation of data accuracy, and signing key regulatory attestations when required.
Study Coordinator / Research Nurse: compiles enrollment numbers, source‑document status, consent forms, and adverse event summaries for the report.
Sponsor Monitor / CRA: reviews the report for monitoring visits, verifies corrective action plans, and escalates findings to sponsor safety teams.

Use the report to create an auditable trail of site activities that supports inspections, sponsor decisions, and IRB continuing review.

Core sections to include in a professional site report

A consistent structure improves clarity during monitoring and audits. Include discrete sections so reviewers can locate enrollment figures, safety data, deviations, and regulatory attachments without searching multiple files.

Study Identification

Protocol number, study title, sponsor, site ID, and reporting period; essential for cross‑referencing with sponsor systems and CRFs.

Enrollment Summary

Subject screen/enroll counts, screen failures, withdrawals, active subjects, and any cohort or strata breakdowns required by protocol.

Adverse Events

Summary of serious and non‑serious events, outcomes, relationship assessments, and dates reported to sponsor/IRB.

Protocol Deviations

List of deviations and violations with dates, impact statements, corrective actions, and whether escalation to IRB or sponsor occurred.

Regulatory Documents

Current CVs, medical licenses, IRB approvals, consent form versions, delegation logs, and equipment calibration records.

Data and Source Status

Status of source documents, query backlogs, outstanding CRF pages, and planned timelines to resolve open data items.

Essential fields to capture on every report

Protocol ID: Unique protocol code

Reporting Period: Start and end dates

Site Identifier: Sponsor site number

PI Name: Principal Investigator

Subject Counts: Enrolled/active numbers

Signatures: PI and preparer

Step-by-step: preparing the site report

Follow a repeatable sequence so each report is complete, verifiable, and consistent across reporting periods.

01

Collect Data: Extract enrollment, visit, and AE logs
02

Summarize Findings: Create concise counts and narratives
03

Attach Documents: Include IRB approval and key regulatory files
04

Sign and Submit: Obtain PI signature and route to sponsor/IRB

Configuring an online report workflow

Standardize field settings and signer authentication when you digitize reports to ensure consistent capture and secure delivery.

Field	Configuration
Authentication Method	Email link or SMS code for signer identity
Conditional Fields	Show follow‑up fields only when triggered
Audit Trail	Capture IP, timestamp, and signer actions
File Formats	Use PDF/A export for archival

Technical and platform considerations for eSubmission

Choose a platform that supports secure authentication, audit trails, and the file formats your sponsor requires.

Integrations: Salesforce, NetSuite, Google Workspace compatibility
Formats: PDF, DOCX, and Excel supported
Security: AES‑256 at rest and TLS in transit

Verify the platform offers HIPAA and 21 CFR Part 11 safeguards if the report includes protected health information or FDA‑regulated records.

Typical submission flow for a finalized report

A predictable submission flow speeds review and reduces back‑and‑forth with monitors and IRBs.

Prepare Report: Compile data and attachments
Obtain Signatures: PI signs electronically or in ink
Route to Sponsor: Send to sponsor contact and CRA
Archive Copy: Store signed PDF in site records

Typical timelines to track when reporting

Timelines vary by sponsor and IRB; use the protocol and monitoring plan to confirm exact deadlines for each report.

Initial Site Setup Report:

Submit after site activation or first enrollment

Monthly Enrollment Summary:

Provide counts and screen/failure details monthly

Serious Adverse Event Reporting:

Report per sponsor/IRB timelines and protocol

Monitoring Visit Report:

Send within sponsor‑specified days after visit

Annual IRB Continuing Review:

Submit required materials per IRB calendar

Common preparation mistakes to avoid

Incomplete attachments such as missing signed consent forms or expired IRB approvals that trigger sponsor queries and audit findings.
Mismatched subject identifiers between the report and source documents, causing reconciliation issues and potential data corrections.
Vague descriptions of deviations without dates, impact assessment, or corrective action plans, leading to extended sponsor follow‑up.
Relying on screenshots or unsecured file transfers instead of signed, timestamped PDFs with audit trails for regulatory review.

Risks and consequences of inaccurate reports

Regulatory Findings: Inspection observations or warning letters

Sponsor Sanctions: Enrollment holds or site suspension

Data Integrity Issues: Query charges and corrections

Patient Safety Risk: Delayed detection of safety signals

Audit Disallowances: Grant or billable expense rejections

Legal Exposure: Contract disputes or liability claims

Comparison: eSignature options relevant to site report workflows

Select a platform that supports HIPAA controls, audit trails, and integration with your document management. Pricing and features vary by vendor and plan.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7‑day free trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently asked questions and troubleshooting tips

Answers to frequent issues encountered when preparing, signing, and submitting Research Investigator Site Reports.

Need help? Contact support

Can an investigator sign electronically?
Yes. Electronic signatures are valid under the federal ESIGN Act (15 U.S.C. §7001) and UETA where adopted, provided intent, consent, attribution, and record retention requirements are met.
Is HIPAA protection required?
If the report contains protected health information, use a platform that supports HIPAA and a signed BAA; retain records per 45 CFR §164.530(j).
How do I handle a missing signature?
Do not alter the signed PDF. Request the missing signature through the platform with an audit trail; document attempts and include the signed timestamp.
What if the sponsor requests additional detail?
Provide an addendum with dated entries and supporting source documents; note the report version and include PI attestation of accuracy.
Are remote notaries acceptable?
Remote online notarization (RON) is state‑dependent; verify state notary rules and retention of audio‑video recordings per the state notary commission.
How long should signed reports be retained?
Retain signed reports per study terms and regulatory standards: at minimum the study term plus three years, longer where HIPAA, FDA, or grant rules apply.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now